CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial Post author: Post published:April 25, 2024 Post category:News Feed Post comments:0 Comments Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas. You Might Also Like Poor health, stress in 20s takes toll in 40s with lower cognition July 4, 2024 AI study reveals individuality of tongue’s surface December 14, 2023 Human brain cancers fire electrical impulses — researchers reveal unexpected hybrid cell spiking the signals September 5, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Human brain cancers fire electrical impulses — researchers reveal unexpected hybrid cell spiking the signals September 5, 2024